DEPOT ADMINISTRATION OF ILOPERIDONE

Treatment or Prevention of Ischaemia Reperfusion Injury

INTRAVENEOUS DOFETILIDE TO REDUCE THE RISK OF DEVELOPING AF/AFL POST CORONARY BYPASS SURGERY

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

POLYNUCLEOTIDES ENCODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF UREA CYCLE DISORDERS

HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS OF TREATING SUBJECTS SUFFERING FROM ATYPICAL HEMOLYTIC SYNDROME

Azaindole rock inhibitors

COMPOSITION CONTAINING BUFFER

FRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY WITH AN OXYGEN THERAPEUTIC

SIALYLATED GLYCOPROTEIN COMPOSITIONS AND USES THEREOF

Controlled-release PTH compound

METHODS FOR EFFECTIVE AND SAFE TREATMENT OF NEUTROPENIA USING DE-MOBILIZED G-CSF

PRESERVATION OF PANCREATIC ISLET GRAFTS IN THE EXTRAHEPATIC SPACE

COMPOSITIONS COMPRISING STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS AND USES THEREOF TO TREAT NEUROLOGICAL DISEASE

MODIFIED IMMUNE-MODULATING PARTICLES

LONG-ACTING INJECTABLE FORMULATIONS AND USE THEREOF

GANAXOLONE FOR USE IN TREATMENT OF ESTABLISHED STATUS EPILEPTICUS

INHIBITORS OF DNA PK AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING SEPSIS

PRODUCTION OF THERAPEUTIC MESENCHYMAL STEM CELL-DERIVED EXOSOMES

Heteronucleic acid containing scpBNA or AmNA

Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy

TREATMENT FOR LUPUS NEPHRITIS USING ANTI-BAFFR ANTIBODIES

Treatment of headache using anti-CGRP antibodies

GIP RECEPTOR AGONIST AND USE THEREOF

THIOAMIDE-MODIFIED PEPTIDES AND USES THEREOF

method for the treatment of pain and a medicinal product for administration during pain

PYRROLO[2,3-D]PYRIMIDIN-2-ONE ANTIMICROBIAL COMPOUNDS

PAIN TREATMENT AGENT

Gel Loaded with Alpha-Emitter Radionuclides

TREATMENT OF COMPLEMENT-MEDIATED DISORDERS

USE OF MEDICAMENT IN TREATMENT OF TUMOR DISEASE

HYDROGEL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF PEDIATRIC GROWTH PLATE INJURIES

USE OF IMMUNE CHECKPOINT INHIBITORS IN CENTRAL NERVOUS SYSTEMS NEOPLASMS

MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION

COMPOSITION COMPRISING BOTULINUM TOXIN

TREATMENT OF ACUTE HEART FAILURE USING NITROUS OXIDE AND CHRONIC HEART FAILURE USING BOTULINUM TOXIN

TREATMENT OF THE DEMENTIAS USING BOTULINUM TOXIN

DOSAGE FORMS OF TISSUE KALLIKREIN 1

URI Agonist/Vasodilator

METHODS OF TUMOUR THERAPY WITH A COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES

METHODS FOR THE TREATMENT OF OSTEOARTHRITIS

METHODS AND COMPOSITIONS FOR MODULATING APPETITE AND INTAKE OF SODIUM

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BRAIN AND NERVOUS SYSTEM DISEASES

Highly active compounds against COVID-19

MINOCYCLINE COMPOUNDS FOR BIODEFENSE

MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS

OLANZAPINE COMPOSITIONS AND METHODS OF USE

SUSTAINED RELEASE OLANZAPINE FORMULATIONS

PHARMACEUTICAL COMPOSITION FOR ENHANCING CELL KILLING, AND USE THEREOF

PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUND SMTP-7

METHODS AND COMPOSITIONS FOR POTENTIATING STEM CELL THERAPIES

INJECTABLE ANESTHETIC SOLUTION WITH A REDUCED BITTERNESS

ISOQUINOLINE-STABILIZED LIPID NANOPARTICLE FORMULATIONS

METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST

METHODS AND COMPOSITIONS FOR INHIBITING A NOXIOUS INSULT

Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy

METHODS OF PRODUCING RPE CELLS

POLYMER AND COMPOSITION THEREOF

PLATFORM TECHNOLOGY FOR TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND/OR AUTOIMMUNOLOGICAL DISEASES

PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME

PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAGONISTS

NON-VIRAL DNA VECTORS EXPRESSING THERAPEUTIC ANTIBODIES AND USES THEREOF

Improved immunoglobulin II

DOSING REGIMENS OF PEPTIDE CONJUGATES OF TOPOISOMERASE I INHIBITORS

LASSA VIRUS VACCINE AND USES THEREOF

METHOD TO MANUFACTURE A STABLE PROTEIN

USE OF PERTUSSIS TOXIN AS A THERAPEUTIC AGENT

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING COVID-19

GIP/GLP1 AGONIST COMPOSITIONS

Treatment of Warts

ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES

HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE

Methods of Producing Improved Immune Cell Populations

MIR200C-EPCAM AXIS REPROGRAMED IMMUNE CELLS FOR ENHANCED ANTI-TUMOR FUNCTION

COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS

SODIUM BICARBONATE INJECTABLE FORMULATION AND METHODS THEREOF

MICRORNA-BASED PARTICLE FOR THE TREATMENT OF DYSREGULATED IMMUNE RESPONSE

TETRODOTOXIN LIQUID FORMULATIONS

PI3K INHIBITORS, NANOFORMULATIONS, AND USES THEREOF

Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan

ENHANCEMENT OF MICROFRACTURE FOR REPAIRING CARTILAGE DEFECTS VIA WNT INHIBITION

Use of Terpenoids and Salicylates as Anesthetics and Analgesics

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE NANOCOMPOSITE GEL FOR CO-DELIVERY OF MULTIPLE MEDICINES OR DRUGS

SINGLE-INJECTION METHODS AND FORMULATIONS TO INDUCE AND CONTROL MULTIPLE OVARIAN FOLLICLES IN BOVINE, CAPRINE, OVINE, CAMELID AND OTHER FEMALE ANIMALS

COAGULATION FACTOR V (F5) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

MODULATING APOLIPOPROTEIN (A) EXPRESSION

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH FIRST-LINE CHEMOTHERAPY IN TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER

Compstatin Analogs with Increased Solubility and Improved Pharmacokinetic Properties

MICRODYSTROPHIN GENE THERAPY ADMINISTRATION FOR TREATMENT OF DYSTROPHINOPATHIES

GENE THERAPY FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

Therapeutic uses for sodium thiosulfate formulations

NEOANTIGEN ADJUVANT AND MAINTENANCE THERAPY

INTRAMUSCULAR COMPOSITIONS OF BOTULINUM NEUROTOXINS

INJECTABLE BOTULINUM TOXIN METHODS FOR TREATING HEADACHES

COMPOSITION FOR TREATING OF FACIAL DYSMORPHISM IN MUCOPOLYSACCHARIDOSIS

GLP-1 compositions and uses thereof

ENHANCED EFFICACY OF TOLEROGENIC VACCINATION

ALTRENOGEST INJECTION AND PREPARATION METHOD AND USE THEREOF

DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE

TREATMENT OF POST-OPERATIVE PAIN VIA SCIATIC NERVE BLOCK WITH SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS

METHODS OF TREATING INJURIES OR CONDITIONS RELATED TO CNS EDEMA

Nucleic Acid Containing Nanoparticles

LIPIDOID NANOPARTICLES FOR THE TREATMENT OF DISEASES AND DISORDERS

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

COAGULATION FACTOR V (F5) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

PH20 polypeptide variants, formulations and uses thereof

STROMAL STEM CELLS

POLYCLONAL ANTIBODY TARGETING SODIUM ION CHANNEL, PHARMACEUTICAL COMPOSITION COMPRISING POLYCLONAL ANTIBODY TARGETING SODIUM ION CHANNEL, AND METHOD FOR TREATING AND/OR PREVENTING CARDIAC ARRHYTHMIA BY USING POLYCLONAL ANTIBODY TARGETING SODIUM ION CHANNEL

ANTIBODIES RECOGNIZING TAU

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA)

COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOX

GENE THERAPIES FOR STARGARDT DISEASE (ABCA4)

GENE THERAPY FOR IMMUNO-ONCOLOGY APPLICATIONS

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

Hyaluronidase enzyme formulations for high volume administration

METHODS FOR PRODUCING STABLE THERAPEUTIC FORMULATIONS IN APROTIC POLAR SOLVENTS

MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF

RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION

ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

TREATMENT OF AUTISM SPECTRUM DISORDERS, OBSESSIVE-COMPULSIVE DISORDER AND ANXIETY DISORDERS

CANNABIDIOL PREPARATIONS AND ITS USES

Combination composition

SYSTEMS AND METHODS FOR PREPARING AND TRANSPORTING AN INJECTABLE SLURRY

Compositions and methods for in utero delivery

NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES

PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY

METHODS OF TREATING DUCHENNE MUSCULAR DYSTROPHY USING PEPTIDE-OLIGONUCLEOTIDE CONJUGATES

METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS

Pharmaceutical Composition

COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME

METHODS FOR TREATING CANCER

Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody

Anti-IL-23 Antibodies

T-cell modulatory multimeric polypeptides and methods of use thereof

SOLID FORMS OF (3R)-N-[2-CYANO-4-FLUORO-3-(3-METHYL-4-OXO-QUINAZOLIN-6-YL)OXY-PHENYL]-3-FLUORO-PYRROLIDINE-1-SULFONAMIDE

D-AMPHETAMINE COMPOUNDS, COMPOSITIONS, AND PROCESSES FOR MAKING AND USING THE SAME

SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY

TREATMENT OF PEANUT ALLERGY WITH TOLERIZING NANOPARTICLES

OXM3 STORAGE AGENT, OXM3 FORMULATION AND PREPARATION METHOD

PSG1 FOR USE IN THE TREATMENT OF OSTEOARTHRITIS

SKELETAL MUSCLE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF

ANTICONVULSANT ACTIVITY OF STEROIDS

METHOTREXATE TREATMENT METHODS

SUSTAINED-RELEASE INJECTABLE COMPOSITION CONTAINING NALTREXONE AND METHOD FOR PREPARING SAME

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

READY-TO-USE ASCORBIC ACID COMPOUND COMPOSITIONS

COMPOSITION FOR PREVENTING OR TREATING NERVOUS SYSTEM DISEASES COMPRISING COMPOUND THAT INHIBITS MTOR SIGNALING PATHWAY AS ACTIVE INGREDIENT

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

EPINEPHRINE COMPOSITIONS AND CONTAINERS

KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS

COMPOSITIONS AND METHODS FOR TARGETED SYSTEMIC DELIVERY TO CELLS

Polymer particles for neutrophil injury

Buffered Lidocaine Injectable Formulations and Methods for Making Same

COMPOSITION COMPRISING AN IGE ANTIBODY

FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS

THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS

MATERIALS AND METHODS FOR NEUROFIBROMIN 2/MERLIN (NF2) GENE THERAPY

Sonosensitization

Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

TREATMENT OF CEREBROVASCULAR EVENTS AND NEUROLOGICAL DISORDERS

DOSING REGIMENS FOR HEMATOPOIETIC STEM CELL MOBILIZATION FOR STEM CELL TRANSPLANTS IN MULTIPLE MYELOMA PATIENTS

BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION

COMPOSITIONS AND METHODS TO IMPROVE THE HOMING AND GRAFTING OF HEMATOPOETIC STEM CELLS

CAR-T CELLS TARGETING UPAR AND USES THEREOF

MODULATED IMMUNODOMINANCE THERAPY

Cancer Cytotoxic Exosome Formulations and Methods for Use in Treating Cancer

USE OF MICRORNA-146A AND NANOCERIA CONJUGATE TO IMPROVE WOUND HEALING AND PROMOTE TISSUE REGENERATION

Tetracycline compositions

METHODS OF TREATMENT USING FUROSEMIDE

TREATMENT OF GLAUCOMA USING ENDOTHELIN RECEPTOR ANTAGONISTS

Autotaxin inhibitor compounds

OPHTHALMIC FORMULATIONS FOR SUSTAINED NEUROPROTECTION

Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis

COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS

PHARMACEUTICAL FORMULATIONS OF TROPOMYOSIN RELATED KINASE (TRK) INHIBITORS

Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate

METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASE

METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA

HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS

COMBINATION OF ANTI-GALECTIN-9 ANTIBODIES AND CHEMOTHERAPEUTICS FOR USE IN CANCER THERAPY

Antibodies to programmed cell death protein 1 that are PD-1 agonists

TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND

Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody

COMPOUNDS USEFUL IN HIV THERAPY

CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE

GANCICLOVIR COMPOSITIONS AND RELATED METHODS

Liquid Protein Formulations Containing Viscosity-Lowering Agents

VACCINES AND IMMUNOGLOBULINS TARGETING AFRICAN SWINE FEVER VIRUS, METHODS OF PREPARING SAME, AND METHODS OF USING SAME

TREATING RESPIRATORY INFECTIONS

USE OF ULTRARAPID ACTING INSULIN

USES OF IL-12 AS A REPLACEMENT IMMUNOTHERAPEUTIC

GENERATING CIK NKT CELLS FROM CORD BLOOD

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS

NON-SURGICAL PREVENTION OF BOAR TAINT AND AGGRESSIVE BEHAVIOR

INJECTABLE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF

TREATMENT OF MULTIPLE SCLEROSIS USING PKC ACTIVATORS

SUSTAINED-RELEASE LIPID PRE-CONCENTRATE

Nanoformulations of Pazopanib, Compositions Comprising the Same and Methods of Treating Osteoarthritis

DEVELOPMENT OF COVID-19 VACCINE USING A DUAL TLR LIGAND LIPOSOME ADJUVANT

Polymer Liposome Hydrogel

DOSING OF siRNA COMPOUNDS TO THE CISTERNA MAGNA

ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES

DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY

MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN THERAPY

MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-BETA (VE-PTP) AND VEGF

COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY

GLUCOSE LEVEL MANAGEMENT WITHOUT CARBOHYDRATE COUNTING

COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A

PHOTODYNAMIC THERAPY COMPRISING TWO LIGHT EXPOSURES AT DIFFERENT WAVELENGTHS

SENSITIZING CELLS TO PROTON RADIATION

PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE

Compositions and Methods For Reducing Immune Intolerance

COMPOSITIONS COMPRISING RELAXIN AND METHODS OF USE THEREOF

Therapeutic RNA

Extracellular Vesicles From Human Induced Pluroptent Stem Cells

PLASMA COMPOSITIONS AND METHODS OF USE THEREOF

BENZODIAZEPINES FOR TREATING OR PREVENTING RESPIRATORY SYNCYTIAL VIRUS INFECTION

PHARMACEUTICAL COMPOSITION OF (S)-KETOROLAC AND PREPARATION METHOD THEREFOR

INCRETIN ANALOG-CONTAINING COMPOSITIONS AND USES THEREOF

Hyperbranched polyglycerol-coated particles and methods of making and using thereof

NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES

NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES

CANCER THERAPY

NUCLEIC ACID DELIVERY TO THE CENTRAL NERVOUS SYSTEM

METHODS FOR MODULATING AN IMMUNE RESPONSE

MeCP2 EXPRESSION CASSETTES

Anhydrous Sodium Thiosulfate and Formulations Thereof

ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS

METHOD FOR INDUCING CELLULAR IMMUNITY TO INFECTION BY SARS-CoV-2

Treatment Of Uterine Fibroids Using Purified Collagenase

OPTOGENETIC VISUAL RESTORATION USING CHRIMSON

READY-TO-USE BIVALIRUDIN COMPOSITIONS

Conjugated Antisense Compounds for Use in Therapy

NITRIC OXIDE-SENSITIVE HYDROGEL

NOVEL PARENTERAL CARBAMAZEPINE FORMULATION

ORGANIC COMPOUNDS

Long Acting Injectable Compositions of Cariprazine or its Pharmaceutically Acceptable Salts

COMPOSITIONS AND METHODS FOR OPIOID ANTAGONIST DELIVERY

METHODS OF TREATING INFECTIONS IN OVERWEIGHT AND OBESE PATIENTS USING ANTIBIOTICS

Isoflavonoid compositions and methods for the treatment of cancer

CAPRIC ACID AND MYRISTIC ACID COMPOSITIONS FOR TREATING CONDITIONS

METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY

Use Of Honokiol In Preparation Of Drug For Treating Meningioma

BIOERODIBLE POLYESTER POLYMER AXITINIB OCULAR IMPLANTS AND RELATED METHODS OF USE

INTRAVENOUS INFUSION DOSAGE FORM FOR PEMETREXED

PREPARATIONS AND METHODS FOR TREATING A GD2 POSITIVE CANCER

SUBCUTANEOUSLY ADMINISTERED ANTI-IL-6 RECEPTOR ANTIBODY

Ophthalmic Compositions, and Ocular Uses Thereof, of Indigo Carmine

NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF

OSTEOTROPIC COMPOSITIONS AND USES THEREOF

CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS

HERPES SIMPLEX VIRUS VACCINE

INFLUENZA VACCINE

Intervention device

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

ANTIMICROBIAL FUSION PEPTIDES

METHODS AND COMPOSITIONS FOR TREATING OCULAR DISORDERS AND DISEASES

Treatment of Bone Marrow Edema (Oedema) With Polysulfated Polysaccharides

PHARMACEUTICAL COMPOSITIONS WITH REDUCED SIDE EFFECT AND METHODS OF USING THE SAME

Stable Antiemetic Emulsions for Parenteral Administration

STABLE DOCETAXEL ALBUMIN NANOPARTICLE COMPOSITION

INJECTABLE MELPHALAN COMPOSITIONS COMPRISING A CYCLODEXTRIN DERIVATIVE AND METHODS OF MAKING AND USING THE SAME

METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING

Induced Expression of Brain Derived Neurotrophic Factor (BDNF) for Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental and/or Metabolic Diseases

ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES

REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor Antibody

ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS

COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY MITOCHONDRIAL DYSFUNCTION, CONTAINING ISOQUINOLINE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

DYSTROPHIN CONSTRUCTS CONTAINING R11-R12

COMBINATION GENE THERAPY FOR TREATMENT OF METASTATIC CANCER

HYDROGEL PRODRUG FOR TREATMENT

INTERCELLULAR ADHESION MOLECULE 1 (ICAM1) ANTIBODY DRUG CONJUGATE AND USES THEREOF

GLP-1R, GIP-R AND/OR GCGR AGONISTS, FORMULATIONS, AND METHODS OF USE

Lipid formulations for delivery of therapeutic agents

VLP stabilized vaccine compositions

Autologous Cancer Vaccines

Astrocyte Interleukin-3 Reprograms Microglia and Limits Alzheimer`s Disease

Methods and Compositions for Treatment of Disease

RECOMBINANT VSV FOR THE TREATMENT OF BLADDER CANCER

TUMESCENT SOLUTION WITH B VITAMINS

FREEZE DRIED DRUG NANOSUSPENSIONS

METHODS AND COMPOSITIONS UTILIZING RRx-001 COMBINATION THERAPY FOR RADIOPROTECTION

COMPOUNDS AND METHODS FOR TREATING CONGENITAL ERYTHROPOIETIC PORPHYRIA

STABLE LEVOTHYROXINE COMPOSITIONS IN APROTIC POLAR SOLVENTS

SUSTAINED RELEASE INJECTABLE THERAPEUTIC FORMULATIONS USING APROTIC POLAR SOLVENTS

METHODS FOR INITIATING SOTALOL

PEG LIPIDS AND LIPID NANOPARTICLES

Methods of use of emulsion formulations of an NK-1 receptor antagonist

Long Acting Injectable Formulation Comprising Risperidone and Biodegradable Polymers